既往感染BA.1后,感染SARS-CoV-2奥密克戎BA.4/5的风险高于BA.2:荷兰,2022年5月2日至7月24日
在荷兰2022年5月2日至7月24日的社区检测阳性者中,采用病例-only设计比较BA.4/5与BA.2感染。BA.4/5感染者中有既往感染史的比例为31.3%,高于BA.2感染者的20.0%(aOR=1.4,95%CI:1.3-1.5)。既往感染BA.1者当前感染BA.4/5的比值更高(aOR=1.9,95%CI:1.5-2.6),提示BA.1诱导的免疫对BA.4/5的保护弱于对BA.2。
要点
- BA.4/5感染者有既往感染史的比例为31.3%,高于BA.2感染者的20.0%(aOR=1.4)。
- 既往感染BA.1者当前感染BA.4/5的比值高于感染BA.2(aOR=1.9,95%CI:1.5-2.6)。
- BA.4/5与BA.2感染的疫苗接种状态分布无显著差异(aOR=1.1)。
核心结论
- 结果提示BA.1诱导的免疫对BA.4/5感染的保护效果弱于对BA.2感染。
研究设计与样本
- 采用病例-only设计,纳入2022年5月2日至7月24日社区检测中经S基因靶标失败(SGTF)区分BA.4/5与BA.2的阳性PCR检测。
- 既往感染通过全基因组测序或SGTF进行变异株分类。
- 采用logistic回归估计SGTF与疫苗接种和/或既往感染的关联,并调整检测周、年龄组和性别。
- 分析纳入19,836例BA.4/5感染者和7,052例BA.2感染者。
主要发现
- BA.4/5感染者中登记有既往SARS-CoV-2感染的比例为31.3%,BA.2感染者中为20.0%。
- 调整检测周、年龄组和性别后,BA.4/5感染与既往感染的aOR为1.4(95%CI:1.3-1.5)。
- BA.4/5与BA.2感染的疫苗接种状态分布无显著差异(aOR=1.1,针对基础免疫和加强免疫接种)。
- 在有既往感染史者中,当前感染BA.4/5者两次感染间隔更短,且既往感染更常由BA.1引起,与当前感染BA.2者相比aOR=1.9(95%CI:1.5-2.6)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundIn summer 2022, SARS-CoV-2 Omicron BA.5 became dominant in Europe. In vitro studies have shown a large reduction of antibody neutralisation for this variant.AimWe aimed to investigate differences in protection from previous infection and/or vaccination against infection with Omicron BA.4/5 vs BA.2.MethodsWe employed a case-only approach including positive PCR tests from community testing between 2 May and 24 July 2022 that were tested for S gene target failure (SGTF), which distinguishes BA.4/5 from BA.2 infection. Previous infections were categorised by variant using whole genome sequencing or SGTF. We estimated by logistic regression the association of SGTF with vaccination and/or previous infection, and of SGTF of the current infection with the variant of the previous infection, adjusting for testing week, age group and sex.ResultsThe percentage of registered previous SARS-CoV-2 infections was higher among 19,836 persons infected with Omicron BA.4/5 than among 7,052 persons infected with BA.2 (31.3% vs 20.0%). Adjusting for testing week, age group and sex, the adjusted odds ratio (aOR) was 1.4 (95% CI: 1.3-1.5). The distribution of vaccination status did not differ for BA.4/5 vs BA.2 infections (aOR = 1.1 for primary and booster vaccination). Among persons with a previous infection, those currently infected with BA4/5 had a shorter interval between infections, and the previous infection was more often caused by BA.1, compared with those currently infected with BA.2 (aOR = 1.9; 95% CI: 1.5-2.6).ConclusionOur results suggest immunity induced by BA.1 is less effective against BA.4/5 infection than against BA.2 infection.
引用
- Andeweg SP, de Gier B, Vennema H, et al. Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022. Euro Surveill. 2023. PMID: 36795499. doi:10.2807/1560-7917.ES.2023.28.7.2200724
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。